>

Anupam Puri - Dr Reddys Non-Executive Independent Director

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 25px;;'>DR</div>
RDY -- USA Stock  

USD 43.08  0.41  0.96%

  Director
Mr. Anupam P. Puri serves as a NonExecutive Independent Director of the Company. Mr. Anupam Puri was associated with McKinsey Company before joining us. He spearheaded the development of McKinseys India practice, oversaw the Asian and Latin American offi ces, and was an elected member of the Board. He played a variety of other leadership roles during his 30year career there. Before joining McKinsey and Company, he was Advisor for Industrial Development to the President of Algeria, and consultant to General Electrics Center for Advanced Studies. He is currently a management consultant. Mr. Puri holds directorship in Mahindra Mahindra Limited, Tech Mahindra Limited, and the companys whollyowned subsidiary, Dr. Reddys Laboratories Inc., USA
Age: 69  Director Since 2002      
91 40 4900 2900  http://www.drreddys.com
Puri holds an M.Phil. in Economics from Nuffi eld College, Oxford University, UK, an M.A. in Economics from Balliol College, Oxford University, UK and a B.A. in Economics from Delhi University, India.

Management Efficiency

The company has Return on Asset of 7.9 % which means that on every $100 spent on asset it made $7.9 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.39 % implying that it generated $11.39 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 10.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.77 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

Min TangOrigin Agritech Limited
2009
Bonnie BasslerRegeneron Pharmaceuticals
2016
Ellen HoffingPerrigo Company Plc
2008
Frank DAmelioZoetis
2016
David BullockOrigin Agritech Limited
2015
David GreenwayVertex Pharmaceuticals Incorpor
2017
Geoffrey ParkerPerrigo Company Plc
2016
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Laurie BrlasPerrigo Company Plc
2016
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Gregory NordenZoetis
2013
Huda ZoghbiRegeneron Pharmaceuticals
2016
Yingqi XiaOrigin Agritech Limited
2010
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Louise ParentZoetis
2013
Michael BrownRegeneron Pharmaceuticals
1991
Shlomo YanaiPerrigo Company Plc
N/A
Alan GarberVertex Pharmaceuticals Incorpor
2017
William DoyleZoetis
2015
Geoffery MerszeiOrigin Agritech Limited
2016
Rolf ClassonPerrigo Company Plc
2017

Company Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing DirectorView
MARC KIKUCHI, Chief Executive Officer, North America GenericsView
Hans Hasler, Additional Independent DirectorView
Leo Puri, Non-Executive Independent DirectorView
Sandeep Poddar, Compliance Officer, Company SecretaryView
Satish Reddy, Co-Chairman of the BoardView
Kedar Upadhye, IR Contact OfficerView
Samiran Das, Executive Vice President Head - FTO and GGPMView
Sauri Gudlavalleti, Global Head of Integrated Product Development OrganizationView
YUGANDHAR PUVVALA, Global Head of Supply ChainView
Amit Biswas, Executive Vice President - Integrated Product DevelopmentView
Ravi Bhoothalingam, Non-Executive Independent DirectorView
Alok Sonig, Senior Vice President & India Business Head (Generics)View
Allan Oberman, Non-Executive Independent DirectorView
J Ramachandran, Executive Vice President-Management Systems and Corporate InitiativesView
Prasad Menon, Lead Non-Executive Independent DirectorView
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)View
Abhijit Mukherjee, COOView
Anil Namboodiripad, Global Head of Proprietary ProductsView
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCREView
SANJAY SHARMA, Global Head of ManufacturingView
Shikha Sharma, Non-Executive Independent DirectorView
Sridar Iyengar, Non-Executive Independent DirectorView
Ganadhish Kamat, Executive Vice President and Global Head-QualityView
Sripada Chandrasekhar, President, Global Head of HR and Member of Management CouncilView
Omkar Goswami, Non-Executive Independent DirectorView
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAIView
Kalpana Morparia, Non-Executive Independent DirectorView
Bharat Doshi, Non-Executive Independent DirectorView
J Moreau, Non-Executive Independent DirectorView
Raymond Vre, Global Head of BiologicsView
Raghav Chari, Senior Vice President - Proprietary ProductsView
Bruce Carter, Non-Executive Independent DirectorView
Saunak Savla, IR Contact OfficerView
Ashok Ganguly, Non-Executive Independent DirectorView
Umang Vohra, Executive Vice President Head - North America GenericsView
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)View
Cartikeya Reddy, Senior Vice President Head - BiologicsView
Anupam Puri, Non-Executive Independent DirectorView
Archana Bhaskar, Chief Human Resource OfficerView
Deepak Sapra, Global Head of PSAIView

Stock Performance Indicators

Return On Equity11.39
Return On Asset7.90
Profit Margin9.50
Current Valuation7.43 B
Shares Outstanding165.77 M
Shares Owned by Insiders0.04
Shares Owned by Institutions13.85